Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This is a 3-month, randomized, parallel-group study with 2 periods, comparing the efficacy
and the safety of rosuvastatin 20 mg versus atorvastatin 80 mg in patients with an acute
coronary syndrome (ACS).